Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2019Journal of Clinical NeurologyOpen Access

Combined Assessment of Serum Alpha-Synuclein and Rab35 is a Better Biomarker for Parkinson's Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

HWHung‐Li WangLinkou Chang Gung Memorial HospitalCLChin-Song LuSAIC-GM (China)TYTu‐Hsueh YehTaipei Medical University Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2019) studied this question.

synapsesocial.com/papers/6aa658636cd58dd9e9f4de7bhttps://doi.org/10.3988/jcn.2019.15.4.488
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK12015 · 190 citations
  2. 2Uric acid in Parkinson's disease2008 · 127 citations
  3. 3Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease2011 · 194 citations
  4. 4LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation2018 · 152 citations